Townsquare Capital LLC Veracyte, Inc. Transaction History

Townsquare Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Nov 13, 2023	SELL	$20.96 - $26.99 $262,754 - $338,346	-12,536 Reduced 55.78%	9,937 $253,000
Q1 2023 May 11, 2023	SELL	$20.58 - $27.89 $7,017 - $9,510	-341 Reduced 1.49%	22,473 $501,000
Q4 2022 Feb 13, 2023	BUY	$15.31 - $29.94 $149,088 - $291,555	9,738 Added 74.47%	22,814 $541,000
Q3 2022 Nov 10, 2022	SELL	$16.58 - $27.9 $193,886 - $326,262	-11,694 Reduced 47.21%	13,076 $217,000
Q2 2022 Aug 08, 2022	BUY	$15.45 - $29.52 $382,696 - $731,210	24,770 New	24,770 $493,000
Q1 2022 Apr 28, 2022	SELL	$21.94 - $42.51 $296,804 - $575,075	-13,528 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$36.09 - $53.79 $138,369 - $206,230	3,834 Added 39.55%	13,528 $557,000
Q3 2021 Nov 15, 2021	BUY	$35.62 - $52.97 $150,708 - $224,116	4,231 Added 77.45%	9,694 $450,000
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $179,951 - $309,315	5,463 New	5,463 $218,000

316

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.23B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.